NIDA’s Dr. Kenner C. Rice Receives Prestigious
Smissman Award
Longtime NIH Scientist Honored for Research
on Drug Abuse
Dr. Kenner C. Rice — whose research has led to the development
of compounds or medications that have the potential to treat or
prevent drug addiction — has been selected to receive the
2007 Smissman Award presented by the American Chemical Society
(ACS). Dr. Rice, chief of the Chemical Biology Research Branch
of the National Institute on Drug Abuse (NIDA), National Institutes
of Health (NIH), will be recognized at the ACS national meeting
in August.
Among Dr. Rice’s contributions spanning a 35-year career are the
development of the NIH Opiate Total Synthesis, which allows medical
opiates to be produced synthetically in any quantity, offering
opiate researchers independence from foreign sources of opium and
providing insights for the development of new non-opioid drugs.
Rice’s work also led to the discovery of an imaging agent for positron
emission tomography (PET) — a medical imaging technique for
study of biochemistry in living humans — that is now being
used to study how opioid drugs work in the brain; and the development
of medications that prevent cocaine self-administration in rhesus
monkeys. These agents may be useful in treating cocaine and methamphetamine
abuse in humans as well. Currently, no effective medication therapies
exist for addiction to these stimulant drugs.
“Dr. Rice is indeed deserving of this prestigious honor,” said
NIH Director Elias A. Zerhouni, M.D. “During his tenure at NIH
he has designed and directed the synthesis of many drugs and research
tools that have helped identify and characterize different drug
effects and interactions. His fellowship programs have helped to
create a whole new generation of scientists producing exciting
research in the fields of organic and medicinal chemistry.”
Since joining the NIH in 1972, Dr. Rice has mentored more than
70 postdoctoral fellows from 20 countries, many of whom have gone
on to prominent scientific positions in industry, government, and
academia. He has authored or coauthored more than 600 published
papers and has over 40 patents.
Dr. Rice received his BS degree from the Virginia Military Institute
in 1961. He then received his doctorate in organic chemistry from
the Georgia Institute of Technology in 1966, where he also conducted
postdoctoral work. He conducted antimalarial research at Walter
Reed Army Medical Center as an active duty member of the Army,
and also was a senior scientist at Ciba-Geigy for three years,
before joining the National Institute of Arthritis, Metabolism,
and Digestive Diseases (now the National Institute of Diabetes
and Digestive and Kidney Diseases) as a senior staff fellow in
1972. Dr. Rice moved to NIDA in 2006 — the research program
that Dr. Rice presently directs there began in 1939 and is one
of the oldest continuous programs at NIH.
The Bristol-Myers Squibb Smissman Award, established by the American
Chemical Society in honor of Professor Edward E. Smissman of the
University of Kansas, is given to a living scientist whose research,
teaching or service has had a substantial impact on the intellectual
and theoretical development of the field of medicinal chemistry.
The National Institute on Drug Abuse is a component of the National
Institutes of Health, U.S. Department of Health and Human Services.
NIDA supports most of the world's research on the health aspects
of drug abuse and addiction. The Institute carries out a large
variety of programs to ensure the rapid dissemination of research
information to inform policy and improve practice. Fact sheets
on the health effects of drugs of abuse and further information
on NIDA research can be found on the NIDA web site at www.drugabuse.gov.
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes and
Centers and is a component of the U.S. Department of Health and
Human Services. It is the primary federal agency for conducting
and supporting basic, clinical and translational medical research,
and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and
its programs, visit www.nih.gov.
|